Jones Hill Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Jones Hill Capital's MDGL Position: Q3 2026 in Review
Jones Hill Capital sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2026, closing a stake of 52,545 shares — an estimated $28.2M sold.
Jones Hill Capital first reported a position in MDGL in Q2 2026 and held it in 1 quarter. The position peaked at $28.2M in Q2 2026. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Jones Hill Capital reported no remaining Madrigal Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Jones Hill Capital sold 52,545 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $28.2M.
- Jones Hill Capital first reported a position in Madrigal Pharmaceuticals in Q2 2026 and held it in 1 quarter.
- Jones Hill Capital's Madrigal Pharmaceuticals position peaked at $28.2M in Q2 2026.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Jones Hill Capital's 13F filing for Q3 2026, filed 13 Nov 2026.